The global Erectile Dysfunction Drugs market was valued at US$ 5375.7 million in 2019 and is expected to reach US$ 8119.6 million by the end of 2026, growing at a CAGR of 6.0% during 2021-2026.
Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
The classification of Erectile Dysfunction Drugs includes Sildenafil, Tadalafil and others, and the proportion of Sildenafil in 2018 is about 99.85%, and the proportion is in decreasing trend from 2014 to 2018.Erectile Dysfunction Drugs is widely used through Hospital Pharmacies, Private Clinics, Retail Pharmacies, E-Commerce (B2B) and E-Commerce (B2C). The most proportion of Erectile Dysfunction Drugs is used for Hospital Pharmacies, and the sales proportion in 2018 is 29.24%.North America is the largest consumption place, with a consumption market share nearly 39.05% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 30.52%. Despite of increasing demand for erectile dysfunction drugs, this market is going to experience a decline in forecast period due to patent expiration of major brands. On the contrary, it will provide the key opportunity for generic manufacturers to enter the market. Generic drugs are the promising opportunity for this market.
Global Erectile Dysfunction Drugs Market: Drivers and Restrains
The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and about each type from 2016 to 2027. This section mentions the volume of production by region from 2016 to 2027. Pricing analysis is included in the report according to each type from the year 2016 to 2027, manufacturer from 2016 to 2021, region from 2016 to 2021, and global price from 2016 to 2027.
A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.
Global Erectile Dysfunction Drugs Market: Segment Analysis
The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027.
Key Companies profiled in this report are Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Metuchen Pharma, Seoul Pharma, CSBIO and more in terms of market share by sales, revenue, average pricing, product type, margins, recent developments etc.
Segment by Type
Segment by Application
- Hospital Pharmacies
- Private Clinics
- Retail Pharmacies
- E-Commerce (B2B)
- E-Commerce (B2C)
Table of Content:
1 Erectile Dysfunction Drugs Market Overview
2 Erectile Dysfunction Drugs Market Competition by Manufacturers
3 Erectile Dysfunction Drugs Retrospective Market Scenario by Region
4 Global Erectile Dysfunction Drugs Historic Market Analysis by Type
5 Global Erectile Dysfunction Drugs Historic Market Analysis by Application
6 Key Companies Profiled
7 Erectile Dysfunction Drugs Manufacturing Cost Analysis
8 Marketing Channel, Distributors and Customers
9 Erectile Dysfunction Drugs Market Dynamics
10 Global Market Forecast
11 Research Finding and Conclusion
12 Methodology and Data Source
Company Name: The Market Reports
Contact Person: Shirish Gupta